← IndicationsOpen filtered programs
Landscape
Genetic Hearing Loss
Genetic Hearing Loss has 9 tracked records across 1 named organizations, including 0 strong-evidence records and 2 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.
9
Pipeline Records
strong evidence + caveats + candidates
0
Strong Evidence
9 checked records with caveats
2
Active Programs
currently active
0
Marketed / Approved
commercial or approved
1
Organizations
companies, sponsors, and institutions
Competitive Density
7/100
organization breadth + program volume
Pipeline Velocity
16/100
active and late-stage share
Evidence Coverage
0/100
share strong evidence
Completion Signal
0/100
late-stage, approved, or marketed
Attrition Rate
11/100
share discontinued
Concentration
100/100
top-organization share
Programs by Stage
Observational/NA2 · 22%
Not applicable7 · 78%
Trial / Program Status
Active2 · 22%
Completed4 · 44%
Discontinued1 · 11%
Unknown2 · 22%
Modality Breakdown
Diagnostic2 · 22%
Genetic/Biomarker Study2 · 22%
Genetic/Diagnostic Sequencing2 · 22%
Biomarker/Specimen Collection1 · 11%
Cochlear/Auditory Implant1 · 11%
Genetic Screening Test1 · 11%
Program Types
Diagnostic8 · 89%
Device1 · 11%
Top Organizations
Institution-led study9 · 100%
Population Tags
genetic8 · 89%
pediatric6 · 67%
adult3 · 33%
cochlear-implant2 · 22%
familial2 · 22%
newborn2 · 22%
screening2 · 22%
cisplatin-ototoxicity1 · 11%
congenital1 · 11%
diagnostic-study1 · 11%
Strong-Evidence Programs
0 recordsNo strong-evidence records yet for this indication.
Checked Records With Caveats
9 recordsAP-HP OTOPLAT platinum ototoxicity pharmacogenetics studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Genetic/Biomarker StudyNot applicableCompleted88% confidence
Nantong newborn deafness-gene screening cohortStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Active
Genetic Screening TestNot applicableActive88% confidence
UNC NC NEXUS newborn exome sequencing studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Genetic/Diagnostic SequencingNot applicableCompleted88% confidence
Dominant deafness genetic epidemiology blood-sample studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Genetic/Biomarker StudyNot applicableCompleted87% confidence
Cochlear implant stimulation-parameter physiology studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Cochlear/Auditory ImplantNot applicableCompleted87% confidence
CMV perilymphatic-fluid diagnostic study during cochlear implantationStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Unknown
Biomarker/Specimen CollectionNot applicableUnknown84% confidence
Hearing-impairment exome sequencing studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Unknown
Genetic/Diagnostic SequencingNot applicableUnknown84% confidence
Jessa DFNA9 Vestibulopathy Imaging and Genetics StudyStatus caveat
Sponsor / Institution: Institution-led study · Observational/NA · Active
DiagnosticObservational/NAActive84% confidence
POU4F3 and SLC17A8 Deafness Genetic Testing StudyStatus caveat
Sponsor / Institution: Institution-led study · Observational/NA · Discontinued
DiagnosticObservational/NADiscontinued73% confidence